Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
16.76
+0.20 (1.21%)
At close: Jun 27, 2025, 4:00 PM
16.80
+0.04 (0.24%)
After-hours: Jun 27, 2025, 7:47 PM EDT
Teva Pharmaceutical Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$24.50
Upside
+46.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $24 → $23 | Strong Buy | Maintains | $24 → $23 | +37.23% | Jun 26, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +43.20% | Jun 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +49.16% | May 28, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $21 → $23 | Hold → Buy | Upgrades | $21 → $23 | +37.23% | May 12, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +31.26% | May 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +19.33% | Mar 6, 2025 |
| UBS | UBS | Strong Buy Maintains $30 → $27 | Strong Buy | Maintains | $30 → $27 | +61.10% | Jan 30, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +55.13% | Jan 30, 2025 |
| UBS | UBS | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +79.00% | Jan 23, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +79.00% | Jan 17, 2025 |
| Barclays | Barclays | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +67.06% | Dec 18, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +49.16% | Oct 23, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +7.40% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +55.13% | Sep 3, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +31.26% | Aug 1, 2024 |
| UBS | UBS | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +43.20% | Jul 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.